An in situ study of bioenergetic propertis of BHK21/C13 cells treated with Karnozin EXTRA® and NOW LCarnosine® (CROSBI ID 730632)
Prilog sa skupa u časopisu | sažetak izlaganja sa skupa | međunarodna recenzija
Podaci o odgovornosti
Popović, Aleksandra ; Drljača, Jovana ; Popović, Milan ; Miljković, Dejan ; Bulajić, Dragica ; Kladar, Nebojša ; Čapo, Ivan ; Marinović, Jasna ; Ljubković, Marko
engleski
An in situ study of bioenergetic propertis of BHK21/C13 cells treated with Karnozin EXTRA® and NOW LCarnosine®
BHK21/C13 cell line are healthy fibroblasts derived from baby hamster kidneys of five unsexed, 1dayold hamsters, which produce ATP predominantly by oxidative phosphorylation. Little is known about the effect of carnosine on their metabolic profile. Herein, in the presence of aqueous solution of the capsules Karnozin EXTRA® and NOW LCarnosine®, corresponding to the concentractions of lcarnosine from the capsules of 2, 5 and 10mM, cells were incubated for 24h. Afterwards, we analysed basal respiration of intact cells, the maximal capacity of the mitochondrial electron transport system and the activity of respiratory chain complexes I, II and IV of treated cells. Mitochondrial respiration is measured using polarography with a Clarktype electrode (Oxygraph system, UK) at 37°C. The results demostrate that the presence of 2 and 5mM aforementioned capsules leads to an increase in the value of all analyzed parameters compared to control (p< 0.001). The mean value of basal respiration, maximal capacity of the mitochondrial electron transport system and the activities of complexes I, II and IV in Karnozin EXTRA® treated cells are higher in comperison with control and the groups treated with NOW LCarnosine® (p< 0.001). In contrast, in the presence of 10mM aqueous solution of tested capsules there was a decrease in the value of all parameters, comparing to control (p< 0.001). We conclude that Karnozin EXTRA® led to a significant improvement in BHK21/C13 cells metabolic profile, compared to NOW LCarnosine®. Carnosine in this formulation may be an endogenous regulator of fibroblast energy metabolism and a clinically safe therapeutic agent.
carnosine ; energy metabolism, mitochondria ; respiration
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o prilogu
254-255.
2021.
nije evidentirano
objavljeno
10.1002/2211-5463.13205
Podaci o matičnoj publikaciji
FEBS Open Bio
John Wiley & Sons
2211-5463
Podaci o skupu
45th FEBS Virtual Congress
poster
03.07.2021-08.07.2021
Ljubljana, Slovenia
Povezanost rada
nije evidentirano